Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure

Kvien, 2004, Epidemiology and burden of illness of rheumatoid arthritis, Pharmacoeconomics, 22, 1, 10.2165/00019053-200422001-00002 Salliot, 2009, Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials, Ann Rheum Dis, 68, 25, 10.1136/ard.2007.083188 Gomez Reino, 2011, [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients], Reumatol Clin, 7, 284 Weinblatt, 2012, Efficacy and safety of certolizumab pegol in a broad population of patients with active rheumatoid arthritis: results from the REALISTIC phase IIIb study, Rheumatology (Oxford), 51, 2204, 10.1093/rheumatology/kes150 Bombardieri, 2007, Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice, Rheumatology, 46, 1191, 10.1093/rheumatology/kem091 Genovese, 2002, Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes, Arthrit Rheumatol, 46, 1443, 10.1002/art.10308 Reynolds, 2012, When is switching warranted among biologic therapies in rheumatoid arthritis?, Expert Rev Pharmacoecon Outcomes Res, 12, 319, 10.1586/erp.12.27 2011, 367 Rendas-Baum, 2011, Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors, Arthritis Res Ther, 13, R25, 10.1186/ar3249 Keen, 2014, Optimising ultrasonography in rheumatology, Clin Exp Rheumatol, 32, S-13 Möller, 2016, Recomendaciones para el uso de la ecografía y la resonancia magnética en pacientes con artritis reumatoide, Reumatol Clin, 14, 9, 10.1016/j.reuma.2016.08.010 Mandl, 2014, Contributions of ultrasound beyond clinical data in assessing inflammatory disease activity in rheumatoid arthritis: current insights and future prospects, Rheumatology (Oxford), 53, 2136, 10.1093/rheumatology/keu211 Arnett, 1988, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, 31, 315, 10.1002/art.1780310302 Fries, 1980, Measurement of patient outcome in arthritis, Arthritis Rheum, 23, 137, 10.1002/art.1780230202 Prevoo, 1995, Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis, Arthritis Rheum, 38, 44, 10.1002/art.1780380107 Huskisson, 1974, Measurement of pain, Lancet, 2, 1127, 10.1016/S0140-6736(74)90884-8 McHorney, 1993, The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs, Med Care, 31, 247, 10.1097/00005650-199303000-00006 Naredo Sanchez, 2009, [Are imaging techniques necessary for defining remission in rheumatoid arthritis?.], Reumatol Clin, 5, 17 Naredo, 2008, Validity, reproducibility, and responsiveness of a twelve-joint simplified power doppler ultrasonographic assessment of joint inflammation in rheumatoid arthritis, Arthritis Care Res (Hoboken), 59, 515, 10.1002/art.23529 Wakefield, 2005, Musculoskeletal ultrasound including definitions for ultrasonographic pathology, J Rheumatol, 32, 2485 Pope, 2009, The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials, J Rheumatol, 36, 254, 10.3899/jrheum.080479 Zink, 2006, Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials, Arthrit Rheumatol, 54, 3399, 10.1002/art.22193 Kievit, 2010, Long-term effectiveness and safety of TNF-blocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register, Rheumatology, 50, 196, 10.1093/rheumatology/keq325 Díaz-Torné, 2017, Impact of ultrasonography on treatment decision in rheumatoid arthritis: the IMPULSAR study, Rheumatol Int, 37, 891, 10.1007/s00296-017-3689-2 de Miguel, 2017, A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis, Rheumatol Int, 37, 1347, 10.1007/s00296-017-3714-5 Naredo, 2015, Predictive value of Doppler ultrasound-detected synovitis in relation to failed tapering of biologic therapy in patients with rheumatoid arthritis, Rheumatology, 54, 1408, 10.1093/rheumatology/kev006 Sarzi-Puttini, 2016, Ann Rheum Dis, 75, 236 Naredo, 2007, Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression, Arthritis Rheum, 57, 116, 10.1002/art.22461 Hammer, 2011, Ultrasonography shows significant improvement in wrist and ankle tenosynovitis in rheumatoid arthritis patients treated with adalimumab, Scand J Rheumatol, 40, 178, 10.3109/03009742.2010.517549 Filippucci, 2006, Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab, Ann Rheum Dis, 65, 1433, 10.1136/ard.2005.044628 Alivernini, 2017, Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?, Ann Rheum Dis, 76, 1228, 10.1136/annrheumdis-2016-210424 Yoshimi, 2013, Ultrasonography is a potent tool for the prediction of progressive joint destruction during clinical remission of rheumatoid arthritis, Mod Rheumatol, 23, 456, 10.3109/s10165-012-0690-1 Chatzidionysiou, 2015, Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register, Ann Rheum Dis, 74, 890, 10.1136/annrheumdis-2013-204714 Wolf, 2017, Clinical outcomes associated with switching or discontinuation from anti-TNF inhibitors for nonmedical reasons, Clin Ther, 39, 849, 10.1016/j.clinthera.2017.03.005